MRFF - Ovarian Cancer Research Grant

Emerging Priorities and Consumer Driven Research Initiative, National Women's Health Strategy 2019 Ovarian Cancer Research Grant.

Research under this grant opportunity could include (but is not limited to) the following areas:

• Biology and aetiology (basic science, mechanisms of resistance and recurrence, aetiology) 
• Inherent and acquired drug resistance 
• Drug repurposing 
• Experimental models (preclinical models, in vitro models) 
• Epidemiology and prevention (risk, epidemiology, surgical methods, other) 
• Detection pathways to earlier diagnosis, diagnosis of disease subtypes 
• Treatment (new treatments, improving response to existing treatments, managing side effects, radiotherapy)
• Translation of existing or completed clinical trial findings into practice 
• Health services research (healthy service models/patterns of care, patient experience and patient reported outcomes, psychosocial support, quality of life, palliative care).

Closing date is Wednesday, 5 February 2020.

Note: There are multiple MRFF grants with this deadline so please advise Gabrielle Callander or Karen McConalogue ASAP of your intent to apply so they can advise and assist you.

Note: Development Support will be available January 9-21. Minimum Data (NHMRC requirement) by 5pm January 22.

The MRO Guidance and Checklist document can be found here.

This call is separate from the Reproductive Cancers (clinical trial round) which came out last week.